Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients

NCT03686605 is registered in ClinicalTrials.gov with Mahidol University as lead sponsor.

NCT NCT03686605
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686605 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Edmonton Symptom Assessment System (ESAS) as a Screening Tool for Depression in Cancer Pain Patients
Lead sponsor
Mahidol University
Phase
Observational
Overall status
Completed
Start date
September 24, 2018
Completion date
January 31, 2020
Enrollment
49 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

screening tool for depresion in cancer pain patients